Sandbox Reserved 1847: Difference between revisions

Line 5:

These mini proteins target the interaction between ACE2 and SARS-CoV-2 spike protein <ref name="Longxing">PMID:32907861</ref>. The mini binders are small proteins designed to bind to the SARS-CoV-2 spike protein with a greater affinity than ACE2 <ref name="Longxing">PMID:32907861</ref>. These mini binders reduce the viral burden of SARS-CoV-2 in mice <ref name="Case">PMID:34192518</ref>. Minibinders were de novo ITALICS designed to mimic the ACE2 helix, but have a lower dissociation constant, yielding a greater affinity for the spike protein <ref name="Longxing">PMID:32907861</ref>. The binding region between <scene name='10/1075251/Ace2_and_rbd/3'>spike protein and ACE2</scene> (PDB: [https://www.rcsb.org/structure/8K4U 8K4U]) makes it seem like binding region is telling how these proteins were designed. Taking a closer look at the SARS-CoV-2 disease pathway shows where the minibinders target the interaction between ACE2 and SARS-CoV-2 spike protein.

[[Image:~~Untitled presentation~~.jpg|500 px|right|thumb|Figure 1. Image of the individual helices of AHB2, LCB1, and LCB3, respectively.]]

[[Image:Minibinders RBD.jpg|500 px|right|thumb|Figure 1. Image of the individual helices of AHB2, LCB1, and LCB3, respectively, bound to the RBD of the spike protein.]]

Sandbox Reserved 1847: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

Revision as of 17:12, 27 April 2025 view source Lilly Hiester (talk \| contribs) 80 edits No edit summary ← Older edit		Revision as of 17:13, 27 April 2025 view source Lilly Hiester (talk \| contribs) 80 edits No edit summary Newer edit →
Line 5:		Line 5:
	These mini proteins target the interaction between ACE2 and SARS-CoV-2 spike protein <ref name="Longxing">PMID:32907861</ref>. The mini binders are small proteins designed to bind to the SARS-CoV-2 spike protein with a greater affinity than ACE2 <ref name="Longxing">PMID:32907861</ref>. These mini binders reduce the viral burden of SARS-CoV-2 in mice <ref name="Case">PMID:34192518</ref>. Minibinders were de novo ITALICS designed to mimic the ACE2 helix, but have a lower dissociation constant, yielding a greater affinity for the spike protein <ref name="Longxing">PMID:32907861</ref>. The binding region between <scene name='10/1075251/Ace2_and_rbd/3'>spike protein and ACE2</scene> (PDB: [https://www.rcsb.org/structure/8K4U 8K4U]) makes it seem like binding region is telling how these proteins were designed. Taking a closer look at the SARS-CoV-2 disease pathway shows where the minibinders target the interaction between ACE2 and SARS-CoV-2 spike protein.		These mini proteins target the interaction between ACE2 and SARS-CoV-2 spike protein <ref name="Longxing">PMID:32907861</ref>. The mini binders are small proteins designed to bind to the SARS-CoV-2 spike protein with a greater affinity than ACE2 <ref name="Longxing">PMID:32907861</ref>. These mini binders reduce the viral burden of SARS-CoV-2 in mice <ref name="Case">PMID:34192518</ref>. Minibinders were de novo ITALICS designed to mimic the ACE2 helix, but have a lower dissociation constant, yielding a greater affinity for the spike protein <ref name="Longxing">PMID:32907861</ref>. The binding region between <scene name='10/1075251/Ace2_and_rbd/3'>spike protein and ACE2</scene> (PDB: [https://www.rcsb.org/structure/8K4U 8K4U]) makes it seem like binding region is telling how these proteins were designed. Taking a closer look at the SARS-CoV-2 disease pathway shows where the minibinders target the interaction between ACE2 and SARS-CoV-2 spike protein.

	[[Image:~~Untitled presentation~~.jpg\|500 px\|right\|thumb\|Figure 1. Image of the individual helices of AHB2, LCB1, and LCB3, respectively.]]		[[Image:Minibinders RBD.jpg\|500 px\|right\|thumb\|Figure 1. Image of the individual helices of AHB2, LCB1, and LCB3, respectively, bound to the RBD of the spike protein.]]